143 related articles for article (PubMed ID: 20686847)
21. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
[TBL] [Abstract][Full Text] [Related]
22. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
24. Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas.
Kim H; Eun JW; Lee H; Nam SW; Rhee H; Koh KH; Kim H
Exp Mol Pathol; 2011 Apr; 90(2):201-9. PubMed ID: 21185829
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
Yin J; Cui Y; Li L; Ji J; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4489-4497. PubMed ID: 28739744
[TBL] [Abstract][Full Text] [Related]
26. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
[TBL] [Abstract][Full Text] [Related]
27. Loss of CDC4/FBXW7 in gastric carcinoma.
Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
[TBL] [Abstract][Full Text] [Related]
28. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
[TBL] [Abstract][Full Text] [Related]
29. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
30. Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis.
Al-Marzoqee FY; Khoder G; Al-Awadhi H; John R; Beg A; Vincze A; Branicki F; Karam SM
Int J Oncol; 2012 Nov; 41(5):1733-43. PubMed ID: 22922943
[TBL] [Abstract][Full Text] [Related]
31. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
32. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer].
Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
34. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
35. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
36. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
[TBL] [Abstract][Full Text] [Related]
37. Natural history of precursor lesions to gastric carcinoma: growth factors and oncogenes in the metaplasia-dysplasia-carcinoma sequence.
Filipe MI
Eur J Cancer Prev; 1994 Dec; 3 Suppl 2():19-23. PubMed ID: 7735041
[No Abstract] [Full Text] [Related]
38. Bmi-1 expression predicts prognosis for patients with gastric carcinoma.
Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH
J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745
[TBL] [Abstract][Full Text] [Related]
39. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.
Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU
Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil gelatinase-associated lipocalin in gastric carcinoma cells and its induction by TPA are controlled by C/EBPβ.
Du ZP; Yuan HM; Wu BL; Chang JX; Lv Z; Shen J; Wu JY; Chen HB; Li EM; Xu LY
Biochem Cell Biol; 2011 Jun; 89(3):314-24. PubMed ID: 21612443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
